About Hôpital Nord
"Avec 4 hôpitaux et 3 400 lits, l’Assistance Publique - Hôpitaux de Marseille (AP-HM) est le 3ème Centre Hospitalier Universitaire de France. Nos établissements offrent toute la gamme des spécialités, du soin de proximité aux traitements de pointe de pathologies complexes et rares, pour adultes et enfants. Contactez nous ou prenez rendez vous sur le site."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Centre Hospitalier Universitaire de Nīmes
15
Intergroupe Francophone de Cancerologie Thoracique
14
UNICANCER
10
Assistance Publique - Hôpitaux de Paris
9
Hoffmann-La Roche
9
Boehringer Ingelheim
8
Federation Francophone de Cancerologie Digestive
7
Hospices Civils de Lyon
7
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
6
Janssen Research & Development, LLC
6
Vertex Pharmaceuticals Incorporated
6
Clinical Trials at Hôpital Nord
During the past decade, Hôpital Nord conducted 182 clinical trials. In the 10-year time frame, 182 clinical trials started and 38 clinical trials were completed, i.e. on
average, 20.9% percent of trials that started reached the finish line to date. In the past 5 years, 71 clinical trials started and 22 clinical trials were completed. i.e. 31%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
2004-11-01
2010-06-30
Completed
342
Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children
2004-11-01
2006-05-01
Completed
6,635
OPERA: French Observational Study on Patients Implanted With a Guidant PRIZM or Vitality Defibrillator
2002-05-01
2007-08-01
Completed
636
Gemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed, Unresectable Uterine or Soft Tissue Leiomyosarcoma
2005-10-01
2012-08-01
Completed
90
Measure of the Long Term Influence of SPIRIVA® in Acute Respiratory Disorders
2000-10-01
2003-10-01
Completed
1,000
Beluga - Clinical Observations of Automatic Algorithms for Cardiac Pacing
2006-09-01
2010-12-01
Completed
903
Left Main Coronary Artery Stenosis and Angioplasty With Taxus Stent
2005-12-01
2010-01-01
Completed
155
Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
2005-10-01
2012-03-01
Completed
202
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hôpital Nord" #1 sponsor was "Centre Hospitalier Universitaire de Nīmes" with 15 trials, followed by "Intergroupe Francophone de Cancerologie Thoracique" with 14 trials
sponsored, "UNICANCER" with 10 trials sponsored, "Assistance Publique - Hôpitaux de Paris" with 9 trials sponsored and "Hoffmann-La Roche"
with 9 trials sponsored. Other sponsors include 223 different institutions and
companies that sponsored additional 123 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Nord"
#1 collaborator was "AstraZeneca" with 9 trials as a collaborator, "Ministry of Health, France" with 6 trials as a collaborator, "Bristol-Myers Squibb" with 4 trials as a collaborator, "National Cancer Institute, France" with 4 trials as a collaborator and "Daiichi Sankyo Co., Ltd." with 3 trials as a collaborator. Other collaborators include 135 different institutions and companies that were
collaborators in the rest 129 trials.
Clinical Trials Conditions at Hôpital Nord
According to Clinical.Site data, the most researched conditions in "Hôpital Nord" are
"Carcinoma, Non-Small-Cell Lung" (11 trials), "Ulcerative Colitis" (11 trials), "Cystic Fibrosis" (8 trials), "Crohn's Disease" (7 trials) and "Non-Small Cell Lung Cancer" (7 trials). Many other conditions were trialed in "Hôpital Nord" in a lesser frequency.
Clinical Trials Intervention Types at Hôpital Nord
Most popular intervention types in "Hôpital Nord" are "Drug" (159 trials), "Other" (50 trials), "Device" (37 trials), "Procedure" (26 trials) and "Biological" (15 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (37 trials), "Carboplatin" (11 trials), "Pemetrexed" (11 trials), "Cisplatin" (7 trials) and "Docetaxel" (6 trials). Other intervention names were less common.
Clinical Trials Genders at Hôpital Nord
The vast majority of trials in "Hôpital Nord" are
260 trials for "All" genders, 17 trials for "Female" genders and 8 trials for "Male" genders.
Clinical Trials Status at Hôpital Nord
Currently, there are 112 active trials in "Hôpital Nord".
4 are not yet recruiting,
66 are recruiting,
38 are Active, not recruiting,
and 4 are Enrolling by invitation.
In total, there were 143 completed trials in Hôpital Nord,
undefined suspended trials,
and 17 terminated clinical trials to date.
Out of the total trials that were conducted in Hôpital Nord, 2 "Phase 1"
clinical trials were conducted, 58 "Phase 2" clinical
trials and 106 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 10 trials, and there were
also 51 trials that are defined as “Not Applicable".